BrincidofovirFanconi syndrome and worsening renal function following off-label therapy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1838卷 / 1期

关键词：

D O I：

10.1007/s40278-021-89435-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：116 / 116

相关论文

共 50 条

[41] MethotrexateSteatohepatitis following off-label use: case report
Reactions Weekly, 2019, 1768 (1) : 225 - 225
[42] AzacitidineDiarrhoea following off-label use: case report
Reactions Weekly, 2019, 1736 (1) : 48 - 48
[43] TocilizumabNeutropenia following off-label use: case report
Reactions Weekly, 2021, 1853 (1) : 446 - 446
[44] PembrolizumabNeutropenia following off-label treatment: case report
Reactions Weekly, 2021, 1851 (1) : 288 - 288
[45] SunitinibCardiomyopathy following off-label use: case report
Reactions Weekly, 2023, 1971 (1) : 240 - 240
[46] PrednisoloneInefficacy following off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 405 - 405
[47] DaratumumabHypogammaglobulinemia following off-label use: case report
Reactions Weekly, 2019, 1744 (1) : 111 - 111
[48] NivolumabPsoriasis following an off-label use: case report
Reactions Weekly, 2018, 1717 (1) : 214 - 214
[49] GlibenclamideHypoglycaemia following off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 162 - 162
[50] Mycophenolate-mofetilLack of efficacy following off-label therapy: case report
Reactions Weekly, 2021, 1862 (1) : 363 - 363

← 1 2 3 4 5 →